Lauren Merendino insider trades
Open-market stock purchases and sales by Lauren Merendino, Chief Commercial Officer at Day One Biopharmaceuticals, Inc, from SEC Form 4 filings since Apr 15, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $3M |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $809K |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | $1.2M |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Apr 23, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Feb 17, 2026 | DAWN Day One Biopharmaceuticals, Inc | Sold | $67.4K |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 17, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold | $33.2K |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 15, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Sold (not open market) | — |
| Nov 6, 2025 | DAWN Day One Biopharmaceuticals, Inc | Bought (not open market) | — |